Community Corner
Community Letter
U.S. Food and Drug Administration (FDA) Approves Lumvoa™ (veligrotug-vvze)
June 26, 2026
Information
Thyroid Eye Disease Patient Advocacy Organizations – USA
May 14, 2026
Information
What is thyroid eye disease (TED)
May 6, 2026
Information
What are clinical trials
April 14, 2026
Information
ElevaTED Survey Infographic
February 24, 2026
Community Letter
Veligrotug Biologics License Application accepted for filing by the U.S. Food and Drug Administration
December 22, 2025
Information
5 Things to Know About Thyroid Eye Disease
November 10, 2025
Information
Beyond the Eyes: Insights from the ElevaTED Survey on the Lived Experience of Thyroid Eye Disease
October 20, 2025
Blog
Catching up with Colleen Kmiecik, Director of Marketing and Communications at the Autoimmune Association
March 19, 2025
Information
Thyroid Eye Disease: Patient Journey and Potential Patient-Driven Solutions
October 21, 2024
Information
Living with Thyroid Eye Disease
October 18, 2024
Article
The work of patient advocacy organisations supporting people with thyroid eye disease
November 18, 2023
Article
Layla Lohmann’s unpredictable journey living with thyroid eye disease
November 18, 2023
Article
Caring for people with thyroid eye disease: a healthcare professional’s experience
November 18, 2023
Article
Travelling a long road with Graves’ disease and thyroid eye disease (TED): a care partner’s perspective
November 18, 2023
Article
A closer look at the history and science of thyroid eye disease
November 18, 2023
Article
The changing landscape for thyroid eye disease
October 6, 2023
Article
Step by step, a way out of the cave: a patient’s perspective of living with thyroid eye disease
October 5, 2023